E
Eshetu G. Atenafu
Researcher at University Health Network
Publications - 344
Citations - 7613
Eshetu G. Atenafu is an academic researcher from University Health Network. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 40, co-authored 294 publications receiving 5880 citations. Previous affiliations of Eshetu G. Atenafu include Hospital for Sick Children & University of Toronto.
Papers
More filters
Journal ArticleDOI
Vertebral Compression Fracture After Spine Stereotactic Body Radiotherapy: A Multi-Institutional Analysis With a Focus on Radiation Dose and the Spinal Instability Neoplastic Score
Arjun Sahgal,Eshetu G. Atenafu,Samuel T. Chao,Ameen Al-Omair,Nicholas S. Boehling,Ehsan H. Balagamwala,Marcelo Cunha,Isabelle Thibault,Lilyana Angelov,Paul D. Brown,John H. Suh,Laurence D. Rhines,Michael G. Fehlings,Eric L. Chang,Eric L. Chang +14 more
TL;DR: It is concluded that SINS may have utility in predicting patients at high risk of SBRT-induced VCF, in particular, for patients with lytic tumor, spinal misalignment, and a baseline VCF.
Journal ArticleDOI
An update on a systematic review of the use of geriatric assessment for older adults in oncology.
Martine Puts,B. Santos,Jill Hardt,Johanne Monette,Veronique Girre,Eshetu G. Atenafu,E. Springall,Shabbir M.H. Alibhai +7 more
TL;DR: Consistent with the previous review, several domains of GA are associated with adverse outcomes and further research examining effectiveness of GA on treatment decisions and oncologic outcomes is needed.
Journal ArticleDOI
Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors.
Marcelo Cunha,Ameen Al-Omair,Eshetu G. Atenafu,Giuseppina Laura Masucci,Daniel Letourneau,Renee Korol,Eugene Yu,Peter Howard,F. Lochray,Leodante da Costa,Michael G. Fehlings,Arjun Sahgal,Arjun Sahgal +12 more
TL;DR: The presence of kyphotic/scoliotic deformity and the presence of lytic tumor were the only predictive factors of VCF based on the original 6 SINS criteria and patients with lung and hepatocellular tumors and treatment with SBRT of 20 Gy or greater in a single fraction are at a higher risk of V CF.
Journal ArticleDOI
Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis
Valerie Waters,Sanja Stanojevic,Eshetu G. Atenafu,Annie Lu,Yvonne C. W. Yau,Elizabeth Tullis,Felix Ratjen +6 more
TL;DR: Half of FEV1 decline seen in CF patients was associated with pulmonary exacerbations, which supports using time to next exacerbation as a clinical end-point for CF trials.
Journal ArticleDOI
Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease.
Valerie Waters,Yvonne C. W. Yau,Sudha Prasad,Annie Lu,Eshetu G. Atenafu,Ian Crandall,Stephanie Tom,Elizabeth Tullis,Felix Ratjen +8 more
TL;DR: Chronic S. maltophilia infection in patients with CF is associated with a specific immune response to this organism and is an independent risk factor for pulmonary exacerbations.